Prescription Habits of Scleral Lenses for the Management of Corneal Irregularity and Ocular Surface Disease Among Scleral Lens Practitioners.
Journal
Eye & contact lens
ISSN: 1542-233X
Titre abrégé: Eye Contact Lens
Pays: United States
ID NLM: 101160941
Informations de publication
Date de publication:
01 Feb 2023
01 Feb 2023
Historique:
accepted:
22
10
2022
pmc-release:
01
02
2024
pubmed:
15
12
2022
medline:
27
1
2023
entrez:
14
12
2022
Statut:
ppublish
Résumé
To describe prescribing patterns of therapeutic scleral lenses (SLs) in the management of corneal irregularity and ocular surface disease among practitioners who prescribe SLs. Participants ranked treatment options for corneal irregularity and ocular surface disease in the order they would generally consider using them in an electronic survey. Median rank score for each option is reported, along with the percentage of participants assigning first place ranking to each option. The percentage of participants assigning first, second, or third place ranking to each option is also reported. Seven hundred and seventy-eight practitioners participated. Scleral lenses are most frequently considered as the first choice for the management of corneal irregularity based on overall median rank, followed by corneal rigid lenses (rigid gas-permeable [RGPs]). Scleral lenses were the first choice of 42% of participants, followed by RGPs (20%). For ocular surface disease, lubricant drops are most frequently used first, followed by meibomian gland expression, topical cyclosporine or lifitegrast, topical steroids, punctal plugs, and SLs, respectively. Lubricant drops were the first therapeutic option considered for ocular surface disease by 63% of participants and 45% ranked SLs as their sixth, seventh or eighth treatment based on median overall rank. Scleral lenses were identified as the first option for management of corneal irregularity more frequently than RGPs. Scleral lenses are considered for management of ocular surface disease before surgical intervention but after meibomian gland expression, punctal occlusion, and topical medical therapy are attempted.
Identifiants
pubmed: 36517221
doi: 10.1097/ICL.0000000000000963
pii: 00140068-202302000-00002
pmc: PMC9877162
mid: NIHMS1846077
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
46-50Subventions
Organisme : NEI NIH HHS
ID : P30 EY001792
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002733
Pays : United States
Informations de copyright
Copyright © 2022 Contact Lens Association of Ophthalmologists.
Références
Rathi VM, Mandathara PS, Dumpati S. Contact lens in keratoconus. Indian J Ophthalmol 2013;61:410–415.
Pullum K, Anand V. Scleral lenses for keratoconus and corneal transplant. Contact Lens and Anterior Eye 2013;36:e14.
Arumugam AO, Rajan R, Subramanian M, Mahadevan R. PROSE for irregular corneas at a tertiary eye care center. Eye Contact Lens 2014;40:71–73.
DeLoss KS, Fatteh NH, Hood CT. Prosthetic replacement of the ocular surface ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia. Am J Ophthalmol 2014;158:974–982.e2.
Jacobs DS, Carrasquillo KG, Cottrell PD, et al. CLEAR – medical use of contact lenses. Cont Lens Anterior Eye 2021;44:289–329.
Rathi VM, Dumpati S, Mandathara PS, et al. Scleral contact lenses in the management of pellucid marginal degeneration. Cont Lens Anterior Eye 2016;39:217–220.
Mahadevan R, Fathima A, Rajan R, Arumugam AO. An ocular surface prosthesis for keratoglobus and terrien's marginal degeneration. Optom Vis Sci 2014;91:S34–S39.
Asena L, Altınörs DD. Visual rehabilitation after penetrating keratoplasty. Exp Clin Transplant 2016;14:130–134.
Navel V, Barriere JV, Joubert R, et al. Irregular astigmatism management using SPOT scleral lenses in the treatment of corneal ectasia and penetrating keratoplasty. Eye Contact Lens 2021;47:401–407.
Penbe A, Kanar HS, Simsek S. Efficiency and safety of scleral lenses in rehabilitation of refractive errors and high order aberrations after penetrating keratoplasty. Eye Contact Lens 2021;47:301–307.
Kumar M, Shetty R, Lalgudi VG, Vincent SJ. Scleral lens wear following penetrating keratoplasty: Changes in corneal curvature and optics. Ophthalmic Physiol Opt 2020;40:502–509.
Chu HS, Wang IJ, Tseng GA, et al. Mini-scleral lenses for correction of refractive errors after radial keratotomy. Eye Contact Lens 2018;44:S164–S168.
Porcar E, Espana E, Montalt JC, et al. Post-LASIK visual quality with a corneoscleral contact lens to treat irregular corneas. Eye Contact Lens 2017;43:46–50.
Erdinest N, Sabag OP, London N, Solomon A. Quadrant asymmetric design contact lens for visual rehabilitation after eye trauma. Case Rep Ophthalmol 2021;12:330–336.
Scanzera AC, Dunbar G, Shah V, et al. Visual rehabilitation with contact lenses following open globe trauma. Eye Contact Lens 2021;47:288–291.
Schornack MM, Pyle J, Patel SV. Scleral lenses in the management of ocular surface disease. Ophthalmology 2014;121:1398–1405.
Yuksel E, Bilgihan K, Novruzlu S, et al. The management of refractory dry eye with semi-scleral contact lens. Eye Contact Lens 2018;44:e10–e12.
Scanzera AC, Bontu S, Joslin CE, et al. Prevalence of ocular surface disease and corneal irregularity and outcomes in patients using therapeutic scleral lenses at a tertiary care center. Eye Contact Lens 2020;46:364–367.
DeLoss KS, Le HG, Gire A, et al. PROSE treatment for ocular chronic graft-versus-host disease as a clinical network expands. Eye Contact Lens 2016;42:262–266.
Theophanous C, Irvine JA, Parker P, Chiu GB. Use of prosthetic replacement of the ocular surface ecosystem scleral lenses in patients with ocular chronic graft-versus-host disease. Biol Blood Marrow Transplant 2015;21:2180–2184.
Harthan JS, Shorter E. Therapeutic uses of scleral contact lenses for ocular surface disease: Patient selection and special considerations. Clin Optom (Auckl) 2018;10:65–74.
Papakostas TD, Le HG, Chodosh J, Jacobs DS. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis. Ophthalmology 2015;122:248–253.
Shorter E, Harthan J, Nau CB, et al. Scleral lenses in the management of corneal irregularity and ocular surface disease. Eye Contact Lens 2018;44:372–378.
Nau CB, Harthan J, Shorter E, et al. Demographic characteristics and prescribing patterns of scleral lens fitters: The SCOPE study. Eye Contact Lens 2018;44:S265–S272.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–381.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019;95:103208.
Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf 2017;15:575–628.
Bavinger JC, DeLoss K, Mian SI. Scleral lens use in dry eye syndrome. Curr Opin Ophthalmol 2015;26:319–324.
Cotter JM, Rosenthal P. Scleral contact lenses. J Am Optom Assoc 1998;69:33–40.
Rosenthal P, Cotter J. The Boston Scleral Lens in the management of severe ocular surface disease. Ophthalmol Clin North Am 2003;16:89–93.
Heur M, Bach D, Theophanous C, Chiu GB. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome. Am J Ophthalmol 2014;158:49–54.
Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 2007;26:1195–1199.
Lim P, Ridges R, Jacobs DS, Rosenthal P. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. Am J Ophthalmol 2013;156:1095–1101.
Schornack MM, Baratz KH. Ocular cicatricial pemphigoid: The role of scleral lenses in disease management. Cornea 2009;28:1170–1172.
Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: A delphi approach to treatment recommendations. Cornea 2006;25:900–907.